Skip to main content

Site notifications

Amoxicillin 250mg/5mL powder for oral suspension sugar free (Flamingo Pharma)

Section 19A approved medicine
Amoxicillin 250mg/5mL powder for oral suspension sugar free (Flamingo Pharma)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 730 109 715 16
Phone
1800 181 060
Approved until
Status
Current
Medicines in short supply/unavailable
APO-AMOXYCILLIN amoxicillin (as trihydrate) 250mg/5mL powder for suspension bottle - ARTG 137883
Indication(s)

It is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms.

Note. Therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. However, in emergency cases where the causative organism has not been identified, therapy with amoxicillin may be useful. Clinical judgment will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results.

  • Skin and skin structure: Staphylococcus, nonpenicillinase producing; Streptococcus; E. coli.
  • Respiratory tract (acute and chronic): H. influenzae; Streptococcus; S. pneumoniae; Staphylococcus, nonpenicillinase producing; E. coli.
  • Genitourinary tract (complicated and uncomplicated, acute and chronic): E.coli P.mirabilis and Strep. faecalis.
  • Gonorrhoea: N. gonorrhoea (nonpencillinase producing).
  • Prophylaxis of endocarditis: Amoxicillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.
Images
Picture of Amoxicillin 250mg/5mL powder for oral suspension sugar free (Flamingo Pharma)

Help us improve the Therapeutic Goods Administration site